Bumetanide Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

• News
• Research
• Blogs
• Alerts
• Clinical Trials

Evaluation of the Efficacy and Safety of Bumetanide in Parkinson's Disease
Condition:   Parkinson Disease Interventions:   Drug: Bumetanide white, oblong, scored tablet;   Drug: Placebo white, oblong, scored tablet Sponsor:   B&A  Therapeutics Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - April 2, 2019 Category: Research Source Type: clinical trials

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: Bumetanide Oral Solution;   Drug: Placebo Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: BUMETANIDE/S95008;   Drug: PLACEBO Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: Bumetanide Oral Solution;   Drug: Placebo Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children Aged From 2 to Less Than 7 Years Old With Autism Spectrum Disorder.
Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: BUMETANIDE/S95008;   Drug: PLACEBO Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials

Efficacy and Safety of Bumetanide Oral Liquid Formulation in Children and Adolescents Aged From 7 to Less Than 18 Years Old With Autism Spectrum Disorder
Condition:   Autism Spectrum Disorder (ASD) Interventions:   Drug: Bumetanide Oral Solution;   Drug: Placebo Sponsors:   Institut de Recherches Internationales Servier;   ADIR, a Servier Group company Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 23, 2018 Category: Research Source Type: clinical trials